In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

Large-cap dividend stocks will make sense as rates continue lower next year. These four have yields greater than the 10-year ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

In the latest trading session, Pfizer (PFE) closed at $26.64, marking a +1.29% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.88% for the day. Meanwhile, the ...

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centred on text messages she exchanged with the head of vaccine maker Pfizer during negotiations for Covid jabs, her lawyer ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.